Arcadia Biosciences, Inc. (RKDA)
USD 3.52
(-1.95%)
USD 3.52
(-1.95%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1 Million USD | -50.07% |
| 2022 | 2.01 Million USD | -38.77% |
| 2021 | 3.29 Million USD | -64.78% |
| 2020 | 9.35 Million USD | 317.69% |
| 2019 | 2.23 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | -100.0% |
| 2016 | 25.12 Million USD | 0.79% |
| 2015 | 24.93 Million USD | 72.23% |
| 2014 | 14.47 Million USD | -0.61% |
| 2013 | 14.56 Million USD | 82.05% |
| 2012 | 8 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 574 Thousand USD | -30.17% |
| 2024 Q1 | 822 Thousand USD | -18.37% |
| 2023 Q3 | 1.27 Million USD | -16.66% |
| 2023 Q2 | 1.52 Million USD | -14.04% |
| 2023 FY | 1 Million USD | -50.07% |
| 2023 Q4 | 1 Million USD | -20.77% |
| 2023 Q1 | 1.77 Million USD | -12.05% |
| 2022 Q3 | 2.25 Million USD | -9.58% |
| 2022 Q4 | 2.01 Million USD | -10.55% |
| 2022 FY | 2.01 Million USD | -38.77% |
| 2022 Q1 | 2.74 Million USD | -16.67% |
| 2022 Q2 | 2.49 Million USD | -9.14% |
| 2021 Q4 | 3.29 Million USD | -13.54% |
| 2021 Q3 | 3.81 Million USD | -51.87% |
| 2021 Q2 | 7.91 Million USD | 10.4% |
| 2021 Q1 | 7.17 Million USD | -23.33% |
| 2021 FY | 3.29 Million USD | -64.78% |
| 2020 Q1 | 5.99 Million USD | 167.93% |
| 2020 FY | 9.35 Million USD | 317.69% |
| 2020 Q4 | 9.35 Million USD | -1.84% |
| 2020 Q2 | 9.1 Million USD | 51.76% |
| 2020 Q3 | 9.52 Million USD | 4.65% |
| 2019 Q4 | 2.23 Million USD | 1.96% |
| 2019 FY | 2.23 Million USD | 0.0% |
| 2019 Q1 | 2.34 Million USD | 0.0% |
| 2019 Q2 | 2.2 Million USD | -6.06% |
| 2019 Q3 | 2.19 Million USD | -0.32% |
| 2018 FY | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2017 Q1 | 25.17 Million USD | 0.19% |
| 2017 Q2 | 25.22 Million USD | 0.2% |
| 2017 FY | - USD | -100.0% |
| 2017 Q3 | - USD | -100.0% |
| 2017 Q4 | - USD | 0.0% |
| 2016 Q1 | 24.97 Million USD | 0.19% |
| 2016 Q4 | 25.12 Million USD | 0.2% |
| 2016 Q3 | 25.07 Million USD | 0.2% |
| 2016 Q2 | 25.02 Million USD | 0.2% |
| 2016 FY | 25.12 Million USD | 0.79% |
| 2015 Q4 | 24.93 Million USD | 7.92% |
| 2015 FY | 24.93 Million USD | 72.23% |
| 2015 Q3 | 23.1 Million USD | 1.3% |
| 2015 Q1 | 12.95 Million USD | -10.53% |
| 2015 Q2 | 22.8 Million USD | 76.09% |
| 2014 Q3 | 14.54 Million USD | 1.94% |
| 2014 Q4 | 14.47 Million USD | -0.51% |
| 2014 Q2 | 14.27 Million USD | 0.0% |
| 2014 FY | 14.47 Million USD | -0.61% |
| 2014 Q1 | - USD | -100.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q4 | 14.56 Million USD | 0.0% |
| 2013 FY | 14.56 Million USD | 82.05% |
| 2012 FY | 8 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bioceres Crop Solutions Corp. | 259.66 Million USD | 99.612% |
| N2OFF, Inc. | 47.69 Thousand USD | -2011.286% |
| Yield10 Bioscience, Inc. | 3.17 Million USD | 68.313% |